Table 1 Patient disease and treatment details
From: Oesophageal IGRT considerations for SBRT of LA-NSCLC: barium-enhanced CBCT and interfraction motion
Patient | Sex | Age | TNM | Stage | Laterality | Involved nodal stations | PTV volume (cc) | Overlap volume of PTV with oesophagus (cc) | Contoured oesophagus length (cm) | No. of fractions | No. of CBCTs with barium | No. of CBCTs without barium | Barium dose (mL) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | F | 78 | T4N2M0 | IIIB | L | 4L, 3A | 1609.9 | 5.96 | 14 | 30 | 3 | 3 | 25 |
2 | M | 68 | T4N2M0 | IIIB | R | 2R, 4R, 7 | 406.4 | 0 | 12.3 | 30 | 2 | 2 | 25 |
3 | M | 84 | T3N2 | IIIB | R | 2R, 4R, 10R | 204.2 | 0.02 | 11.6 | 30 | 3 | 3 | 25 |
4 | F | 52 | T2bN1M0 | IIB | R | 4R, 11R | 337.4 | 0.6 | 8.6 | 30 | 3 | 3 | 25 |
5 | F | 54 | T1N2M0 | IIIA | L | 4R, 4L, 5, 6, 7, 10L | 343.3 | 5.86 | 10.3 | 30 | 3 | 3 | 25 |
6 | F | 67 | TXN2M0 | IIIA | R | 7 | 326.3 | 14.2 | 14.8 | 30 | 3 | 3 | 15 |
7 | F | 71 | T1bN2M0 | IIIA | L | 5, 7,10L, | 231 | 13.27 | 12.8 | 20 | 2 | 2 | 15 |
8 | M | 72 | T3N2M0 | IIIB | L | 5 | 513.8 | 8.02 | 11 | 25 | 2 | 2 | 15 |
9 | M | 82 | T4N2M0 | IIIB | R | 10R | 1002.9 | 7.83 | 10.8 | 30 | 3 | 3 | 15 |
10 | M | 82 | T2aN2M0 | IIIA | R | 4R, 7, 8R, 10R, 11R | 481.1 | 5.24 | 14.5 | 20 | 2 | 2 | 15 |
11 | F | 78 | T3N2M1b | IVA | L | 5, 10L | 209 | 3.44 | 11.3 | 25 | 2 | 3 | 10 |
12 | M | 78 | T4N3M1b | IVA | R | 2L, 2R, 3A, 4R, 10R | 548.9 | 4.52 | 15.4 | 15 | 1 | 2 | 10 |
13 | M | 85 | T2bN2M0 | IIIA | R | 2R, 4R, 10R | 485.5 | 1.65 | 13.7 | 30 | 3 | 2 | 10 |
14 | M | 54 | T4N1M0 | IIIA | R | 10R | 1353.2 | 17.63 | 17.3 | 20 | 2 | 2 | 10 |
15 | M | 76 | T4N1M0 | IIIA | L | 10L | 228.8 | 0.08 | 10.8 | 20 | 2 | 2 | 10 |
16 | M | 51 | T3N3M0 | IIIC | R | 1L, 7 | 532.1 | 19.71 | 13.8 | 30 | 2 | 3 | 5 |
17 | F | 75 | T2aN0M0/T1bN0M0* | IB/IA | L | – | 146.4 | 0 | 9.33 | 30 | 3 | 3 | 5 |
18 | M | 55 | T4N0M0 | IIIA | M | – | 283.42 | 8.42 | 10 | 30 | 3 | 3 | 5 |